Macular Degeneration
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
Approved and Donation Ready
This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.
If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.
Fund TypeCo-Pay, Co-insurance & Deductible (medications and office visits), Medical Insurance Premiums
Maximum Award Level$3,000 Per Year
- Household Income Requirements 300% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements Medicare, Medicaid, or Military Benefits
- Must reside and receive treatment in the United States.
About Macular Degeneration
“Macular degeneration, also known as age related macular degeneration (AMD) is caused by the deterioration of the central portion of the retina, known as the macula. The macula is responsible for recording and sending images via the optic nerve from the eye to the brain, as well as focusing central vision in the eye, which controls what a person sees right in front of them. Macular degeneration is referred to as a low vision condition since peripheral vision remains intact. AMD is most common in white adults, affecting one in 14 people over the age of 40, ultimately affecting almost a third of seniors over the age of 80.
There are two forms of macular degeneration, wet (neovascular) and dry (non-neovascular).
Wet AMD, is when new, abnormal blood vessels grow under the retina, these blood vessels may leak, causing scarring of the macula. While Wet AMD is less common, accounting for 10% to 15% of cases, it causes a relatively sudden change in vision that result in serious vision loss.
Dry AMD is common in people over 65, accounting for 85% to 90% of cases, and usually affects both eyes. Dry AMD causes blurred vision or visual distortions as a result of aging along with thinning of macula tissues, or the depositing of yellowish pigment (drusen) under the retina or may be a combination of the two processes. “
- CancerCare866-55-COPAY
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663
